The Hygiology Post ® is presenting information about a company that seems to have much potential to help many people. Both 2012 and 2013 appear to be pivotal years in determining how helpful the patented technologies may actually be for people. Senesco Technologies has continued to update information on its web site (https://www.senesco.com/newsitem.php?id=285; retrieved on 11-04-2013). As a matter of disclosure : The author continues to be a current shareholder in the company.
A recent article in the publication, Seeking Alpha (https://seekingalpha.com/article/1801872-senesco-technologies-a-potential-26-stock-trading-at-5?source=yahoo; obtained on 11-5-2013), titled “Senesco Technologies: A Potential $26 Stock Trading At $5 ” on “Nov 4 2013, 11:09 by: Carl Cachia” began the following way:
“Disclosure: I am long OTC:SNTID. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
It is not often investors can spot a buying opportunity where $26 is on sale for $5. That is what I believe Senesco Technologies (OTC:SNTID) is offering at its current price level. This company is at about as low a baseline from a buying standpoint as anyone who believes in the prospects of its technology could hope for. One person in particular who has made a very loud statement regarding his belief in Senesco is its Chairman, Harlan Waksal. Waksal has had an impressive career in biotech, with his largest success coming as the co-founder of Imclone. His current focus is on Senesco, where he purchased stock at $26/share in 2012 and is personally securing a $3 million credit line for the company. This makes a strong statement considering his knowledge and prior success in the biotech space. It is also reminiscent to me of another successful biotech investor I follow in Phillip Frost and his vocal support of Opko (OPK), which he has been consistently purchasing as it has gone from $4.50 to $10/share in the past year. I believe Senesco will be following this same path in share price appreciation.”
The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.
Louis DeCola, Jr. © 2013 The Hygiology Post ®